Abiopharma

News list

Beynon Roger Paul 🟡 adjusted position in 23.9K shares (3 derivative) of CLEANSPARK, INC. (CLSK) Transaction Date: Mar 09, 2026 | Filing ID: 140956

Full text

News bot April 3, 2026, 1:02 a.m.
🔍 Beynon Roger Paul (Executive)

Company: CLEANSPARK, INC. (CLSK)

Report Date: 2026-03-09
Transaction Summary:
- Total transactions: 5
- Derivative instruments: 3
- Holdings reported: 2
- Total shares acquired: 38,573
- Total shares sold: 7,353
- Total shares held: 140,217
Detailed Transactions and Holdings:
- Acquired 7,353 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: false | shares_owned_after: 140,217.00 | transaction_form_type: 4
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-09 | Code: H | shares_owned_after: 132,864.00
- Sold 7,353 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: M | Exercise: 2026-03-31 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
- Acquired 31,220 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-09 | Code: A | equity_swap_involved: false | shares_owned_after: 31,220.00 | transaction_form_type: 4 | Footnotes: F2, F2
- Holds 7,353 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-09 | Code: H | shares_owned_after: 7,353.00 | Footnotes: F1, F1
Footnotes:
- F1: These RSUs vested on March 31, 2026.
- F2: These RSUs vest in equal quarterly installments on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027.